HVC
AORT icon

Healthcare Value Capital’s Artivion AORT Stock Holding History

Healthcare Value Capital’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-200,000
Closed -$3.99M – 14
2017
Q2 		$3.99M Buy
+200,000
New +$3.58M 7.17% 7

Other funds holding AORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Healthcare Value Capital's AORT Position: Q2 2017 in Review

Healthcare Value Capital sold out of Artivion (AORT) in Q2 2017, closing a stake of 150,000 shares — an estimated $2.69M sold.

Healthcare Value Capital first reported a position in AORT in Q2 2013 and held it in 13 quarters. The position peaked at $4.72M in Q2 2016. 127 funds tracked by Wall St. Rank hold AORT as of Q2 2017.

  • Healthcare Value Capital reported no remaining Artivion position as of Q2 2017 after selling out during the quarter.
  • Healthcare Value Capital sold 150,000 Artivion shares in Q2 2017, an estimated $2.69M.
  • Healthcare Value Capital first reported a position in Artivion in Q2 2013 and held it in 13 quarters.
  • Healthcare Value Capital's Artivion position peaked at $4.72M in Q2 2016.
  • 127 funds tracked by Wall St. Rank held Artivion as of Q2 2017.

Based on Healthcare Value Capital's 13F filing for Q2 2017, filed 10 Aug 2017.